PSY30 Cost Utility Analysis of the Profilaxis Versus On-Demand Treatment With Recombinant Factor IX for the Treatment of Hemophilia B in Mexico
Jun 1, 2012, 00:00
10.1016/j.jval.2012.03.564
https://www.valueinhealthjournal.com/article/S1098-3015(12)00629-8/fulltext
Title :
PSY30 Cost Utility Analysis of the Profilaxis Versus On-Demand Treatment With Recombinant Factor IX for the Treatment of Hemophilia B in Mexico
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)00629-8&doi=10.1016/j.jval.2012.03.564
First page :
A103
Section Title :
Systemic Disorders/Conditions
Open access? :
No
Section Order :
25